Head‐to‐head comparison of TKI and CPI first‐line treatment strategies in advanced renal cell carcinoma—Real‐world data from the German research platform CARAT

Ähnliche Einträge

• Prediction of dose reductions and impact of reduced starting doses of CDK4 /6i on effectiveness in HR ‐positive/ HER2 ‐negative metastatic breast cancer: Real‐world data from the OPAL registry
  von: Patrick Marschner, et al.
  Veröffentlicht: (2026)
• Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315)
  von: Martin Sebastian, et al.
  Veröffentlicht: (2024)
• Flexibilizing employment: an overview
  von: Kim van Eyck
  Veröffentlicht: (2003)
• Head‐to‐head comparison of palbociclib and ribociclib in first‐line treatment of HR‐positive/HER2‐negative metastatic breast cancer with real‐world data from the OPAL registry
  von: Marc Thill, et al.
  Veröffentlicht: (2024)
• La justicia en la República federal de Alemania / Wolfgang Heyde
  von: Heyde, Wolfgang
  Veröffentlicht: (1971)